CO6430490A2 - Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral - Google Patents

Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral

Info

Publication number
CO6430490A2
CO6430490A2 CO11126599A CO11126599A CO6430490A2 CO 6430490 A2 CO6430490 A2 CO 6430490A2 CO 11126599 A CO11126599 A CO 11126599A CO 11126599 A CO11126599 A CO 11126599A CO 6430490 A2 CO6430490 A2 CO 6430490A2
Authority
CO
Colombia
Prior art keywords
biomarkers
expression
diagnosis
oral cavity
soft tissue
Prior art date
Application number
CO11126599A
Other languages
English (en)
Inventor
Harsh M Trivedi
Tao Xu
Ying Yang
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of CO6430490A2 publication Critical patent/CO6430490A2/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1.- Un método para identificar un compuesto útil para el tratamiento de una enfermedad o afección de la cavidad oral, donde dicha enfermedad o afección de la cavidad oral es gingivitis o periodontitis, dicho método comprende:obtener una primera muestra gingival de un mamífero que padece dicha enfermedad o afección de la cavidad oral;obtener una segunda muestra gingival de la cavidad oral de dicho mamífero;poner en contacto dicha primera muestra con un compuesto de prueba;poner en contacto dicha segunda muestra con un control positivo, donde dicho control positivo es un compuesto que se sabe disminuye la expresión de uno o más biomarcadores;establecer en qué medida la expresión de uno o más de dichos biomarcadores es disminuida por dicho compuesto de prueba;establecer en qué medida la expresión de uno o más de dichos biomarcadores es disminuida por dicho control positivo ycomparar la medida en que la expresión de uno o más de dichos biomarcadores se ve disminuida por dicho compuesto de prueba con la medida en que la expresión de uno o más de dichos biomarcadores es disminuida por dicho control positivo;donde un compuesto de prueba que disminuye la expresión de uno o más de dichos biomarcadores en igual o mayor medida que dicho control positivo es un compuesto útil para el tratamiento de dicha enfermedad o afección de la cavidad oral.
CO11126599A 2009-04-01 2011-09-27 Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral CO6430490A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16567409P 2009-04-01 2009-04-01

Publications (1)

Publication Number Publication Date
CO6430490A2 true CO6430490A2 (es) 2012-04-30

Family

ID=42813186

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11126599A CO6430490A2 (es) 2009-04-01 2011-09-27 Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral

Country Status (15)

Country Link
US (1) US8753820B2 (es)
EP (1) EP2414837B1 (es)
JP (1) JP5643288B2 (es)
CN (1) CN102549432B (es)
AR (1) AR076041A1 (es)
BR (1) BRPI1013184A2 (es)
CA (1) CA2753718C (es)
CO (1) CO6430490A2 (es)
MX (1) MX2011008439A (es)
MY (1) MY179250A (es)
RU (1) RU2523383C2 (es)
SG (1) SG173461A1 (es)
TW (1) TWI481870B (es)
WO (1) WO2010115034A2 (es)
ZA (1) ZA201106056B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI405565B (zh) * 2009-04-01 2013-08-21 Colgate Palmolive Co 口腔用組成物之抗－骨質流失及抗－牙周附連喪失之功效
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
WO2018129043A1 (en) * 2017-01-03 2018-07-12 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
AU2018272914A1 (en) 2017-05-24 2020-01-23 Koninklijke Philips N.V. Diagnostics of mild or advanced periodontitis based on salivary IL-1beta and MMP-9
WO2018215596A1 (en) * 2017-05-24 2018-11-29 Koninklijke Philips N.V. Diagnostics of gingivitis based on salivary il-1beta and hgf
US11768207B2 (en) * 2017-05-24 2023-09-26 Koninklijke Philips N.V. Diagnostics of periodontitis based on salivary HGF and MMP-8
US11124833B2 (en) 2017-10-27 2021-09-21 Colgate-Palmolive Company Salivary extracellular RNA biomarkers for gingivitis
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
JPH09511220A (ja) 1993-11-10 1997-11-11 ブリストル‐マイヤーズ スクイブ カンパニー バクテリアによって誘発される炎症性疾患の治療
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
US6482418B1 (en) 1996-06-12 2002-11-19 Henkel Kommanditgesellschaft Auf Aktien Cosmetic and/or pharmaceutical preparations comprising dialkenyl carbonates
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
DK2295968T3 (da) 1999-12-03 2012-12-17 Baxter Healthcare Sa Pyrogenicitetsprøve til anvendelse i forbindelse med automatiserede immunanalysesystemer
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
JP2003530130A (ja) 2000-04-14 2003-10-14 メタボロン インコーポレイテッド メタボロミクスを使用した薬物発見、疾患の処置、及び診断のための方法
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
TW200509958A (en) 2003-02-14 2005-03-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
US7202234B2 (en) 2003-10-24 2007-04-10 Eisai Co., Ltd. Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
SI1701978T1 (sl) 2003-12-03 2009-08-31 Whitehead Biomedical Inst Uporaba topnega t-kadherina za zdravljenje presnovnih bolezni
FI20040572A0 (fi) 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
JP4934812B2 (ja) * 2004-12-21 2012-05-23 国立大学法人 奈良先端科学技術大学院大学 Ｎｆａｔ２発現抑制方法
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
ES2421595T3 (es) 2006-01-10 2013-09-04 Colgate Palmolive Co Métodos para modular receptores de superficie celular para prevenir o reducir la inflamación
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
US8333981B2 (en) 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
JP2012522994A (ja) 2012-09-27
CN102549432B (zh) 2015-03-25
AR076041A1 (es) 2011-05-11
CA2753718A1 (en) 2010-10-07
MX2011008439A (es) 2011-09-06
US20120028261A1 (en) 2012-02-02
US8753820B2 (en) 2014-06-17
AU2010232593A1 (en) 2011-08-25
TW201102653A (en) 2011-01-16
BRPI1013184A2 (pt) 2016-04-12
EP2414837B1 (en) 2015-06-03
ZA201106056B (en) 2015-05-27
JP5643288B2 (ja) 2014-12-17
CA2753718C (en) 2015-06-23
TWI481870B (zh) 2015-04-21
WO2010115034A3 (en) 2010-12-29
WO2010115034A2 (en) 2010-10-07
CN102549432A (zh) 2012-07-04
EP2414837A2 (en) 2012-02-08
RU2523383C2 (ru) 2014-07-20
MY179250A (en) 2020-11-02
RU2011144032A (ru) 2013-05-10
SG173461A1 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
CO6430490A2 (es) Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral
DE602006011896D1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
ES2548508T3 (es) Métodos de tratamiento de enfermedades
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
UA101167C2 (ru) Фармацевтическая композиция, предназначенная для лечения глазной болезни
EA200701600A1 (ru) Способ получения лёгкодоступного клеточного материала из периферической крови и композиция на его основе
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
NO20072120L (no) Enzyme Inhibitor Imaging Agents
BR112014009223A8 (pt) método para o diagnóstico da doença de niemann-pick
AR071034A1 (es) Uso de la catepsina c en el diagnostico de susceptibilidad al dolor y para el tratamiento del dolor
JP2012522994A5 (es)
BR112014005573A2 (pt) Anticorpo monoclonal b7-h6 terapeuticamente ativo contra polipeptídeo b7-h6
AR076113A1 (es) Metodo o sistema que usa biomarcadores para el seguimiento de un tratamiento
NO20076119L (no) Diagnostisk markor for diabetiske vaskulaere komplikasjoner
WO2010047938A3 (en) Mmp activation peptide detection in biological samples
WO2015022646A3 (en) Genetically encoded fret-based mmp-9 activity biosensor and use thereof
EP4183340A4 (en) SAMPLE PAD FOR MEDICAL DIAGNOSTIC KIT AND MANUFACTURING METHOD THEREFOR
MY196578A (en) Method for Determining Stage of Periodontal Disease
ES2570609T3 (es) Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal
EA201500765A1 (ru) Способы лечения сердечно-сосудистых заболеваний
AR076177A1 (es) MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL
WO2018236134A3 (en) METHOD AND KIT FOR THE DIAGNOSIS OF MUSCLE WEAK RELATED DISEASES USING A BLOOD BIOMARKER
JP2012524884A5 (es)
WO2010093214A3 (en) Monoclonal antibody recognizing scye1 and use thereof
CY1124477T1 (el) Βιο-αισθητηρας καi μεθοδος για την εγκαιρη διαγνωση του γλαυκωματος

Legal Events

Date Code Title Description
FG Application granted